Search for: "Pfizer Health AB"
Results 21 - 29
of 29
Sort by Relevance
|
Sort by Date
13 Dec 2010, 11:13 am
Court of Appeal (Civil Division) Carroll v Kynaston [2010] EWCA Civ 1404 (13 December 2010) High Court (Queen’s Bench Division) Smith v ADVFN Plc & Ors [2010] EWHC 3255 (QB) (13 December 2010) High Court (Administrative Court) Public Interest Lawyers v Legal Services Commission [2010] EWHC 3277 (Admin) (13 December 2010) High Court (Patents Court) Pfizer Health AB & Anor v Schwarz Pharma AG & Ors [2010] EWHC 3236 (Pat) (08 December 2010) High Court… [read post]
2 Oct 2010, 8:43 am
ROST ON FOX NEWS: DISCUSSING VYTORIN ON "MONEY FOR BREAKFAST" WSJ on Health-Care Overhaul: "Ahead of these give-backs, they dramatically raise prices," Dr. [read post]
10 Mar 2010, 5:22 am
(Patentcircle) (GenericsWeb) Glazide (Gliclazidium) – Poland: Supreme Administrative Court: Glazide is distinctive (Class 46) Januvia (Sitagliptin) - EU: Partial translation of German Sitagliptin referral to the ECJ (The SPC Blog) Nexium IV (Esomeprazole) – US: Infringement of patent following a Paragraph IV certification: AstraZeneca AB et al. v. [read post]
10 Mar 2010, 5:22 am
(Patentcircle) (GenericsWeb) Glazide (Gliclazidium) – Poland: Supreme Administrative Court: Glazide is distinctive (Class 46) Januvia (Sitagliptin) - EU: Partial translation of German Sitagliptin referral to the ECJ (The SPC Blog) Nexium IV (Esomeprazole) – US: Infringement of patent following a Paragraph IV certification: AstraZeneca AB et al. v. [read post]
28 Sep 2009, 1:31 am
BT Industries AB, 41 Pa. [read post]
28 Sep 2009, 1:31 am
BT Industries AB, 41 Pa. [read post]
28 Sep 2009, 1:31 am
BT Industries AB, 41 Pa. [read post]
24 Sep 2009, 5:09 am
BT Industries AB, 41 Pa. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
